New Chairman for Vaccine Firm Imophoron

Unit DX members Imophoron today announce the appointment of serial biotech entrepreneur and director Damian Marron as their Chairman, to support the development of the company’s groundbreaking vaccine platform and preclinical COVID-19 candidates. An experienced life science executive, Marron’s achievements include multiple company exits, partnerships and fundraising, including deals with top-tier pharmaceutical companies. “Imophoron’s technology [...]

By | 2020-05-28T10:23:05+01:00 May 28th, 2020|News, Press Releases|

New vaccine platform used to develop COVID-19 candidates

UK biotech Imophoron has produced multiple COVID-19 vaccine candidates, based on its novel vaccine platform (named the ADDomer©), within weeks of the virus sequence being made available. Pre-clinical trials to begin within weeks The UK start-up is looking for partners to further the development of the COVID-19 candidates and the ADDomer platform Vaccines based on [...]

By | 2020-04-07T15:44:53+01:00 April 7th, 2020|News, Press Releases|

CytoSeek Raise £1.1 Million for New Cell Therapies to Treat Solid Tumours

Unit DX member CytoSeek has raised £1.1 million in funding to develop next generation cell therapies that could open new ways to treat solid tumours. Presently, treatments for solid tumours, which account for most tumour deaths, are limited by the inability of immune cells to penetrate the tumour microenvironment. CytoSeek’s cell membrane augmentation technology is [...]

By | 2019-11-25T12:03:13+00:00 November 25th, 2019|News, Press Releases|

Unit DX Biotech Start-Up Imophoron Publish Groundbreaking Refrigeration-Independent Vaccine Platform

Imophoron are developing a next-generation vaccine platform that could eliminate the requirement for the cold chain, making it easier to transport vaccines to low- and middle-income countries. Today, Science Advances published the results of their collaboration with tech giant Oracle. The open-access paper details the company’s use of synthetic biology, cryogenic electron microscopy, and high-performance [...]

By | 2019-10-10T12:22:26+01:00 September 26th, 2019|News, Press Releases|

Bristol’s University Enterprise Zone Gets £1.5M Boost for Biotech

£100m government investment to back rising stars of science and innovative small businesses Research England has awarded £1.5 million to the University of Bristol towards developing a new state-of-the-art life sciences incubator with Unit DX, as part of its University Enterprise Zone [UEZ] programme. The funding is part of nearly £100 million government investment that [...]

By | 2019-09-24T15:54:08+01:00 September 20th, 2019|News, Press Releases|

Inductosense Become the First Unit DX Alumni Company

Inductosense, a Bristol scale-up company specialising in ultrasonic non-destructive testing, are the first of our members to graduate from Unit DX after relocating to a new facility this week. The new 5000 sq ft site nearby in St Philips will allow Inductosense to increase their research and production capacities.  We have played a key role [...]

By | 2019-09-04T16:40:30+01:00 September 4th, 2019|News, Press Releases|

Unit DX Members Raise £20m+ in Two Years

Last week we celebrated our second anniversary and the growth of the Bristol science cluster. We hosted an event at the Arnolfini, to showcase the companies' technologies and their successes from the past two years. In the past year, Unit DX has reached 100% occupancy, and the building is now home to 37 science and [...]

By | 2019-05-16T12:25:23+01:00 May 16th, 2019|News, Press Releases|

Nature Chemistry publishes a scientific breakthrough that could be the missing link in two ‘holy grail’ technologies for diabetics.

The paper in Nature Chemistry details the science behind Ziylo’s platform, which Novo Nordisk purchased in August to pioneer a new drug discovery programme developing smart insulins. The deal, which could eventually be worth over USD$800m, was the largest exit on record for a University of Bristol spin-out. Carbometrics, the new vehicle set up by [...]

By | 2019-06-20T16:42:02+01:00 November 21st, 2018|News, Press Releases|

Business Minister visits Unit DX and Bristol BioDesign Institute

The Rt Hon Lord Henley, Parliamentary Under Secretary of State at the Department for Business, Energy and Industrial Strategy (BEIS), visited the University’s Bristol BioDesign Institute today, along with a visit to science incubator, Unit DX. During the afternoon, Lord Henley visited Unit DX and met with biodesign spinouts including: Carbometrics (previously Ziylo); Zentraxa Ltd; [...]

By | 2018-11-07T14:40:58+00:00 October 26th, 2018|News, Press Releases|